Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
2(67%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

3

all time

Status Distribution
Active(2)
Completed(1)

Detailed Status

Recruiting2
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
2
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

completed133%
recruiting267%

Recent Activity

2 active trials
Showing 3 of 3
recruitingnot_applicable

Deciphering Preserved Autonomic Function After Spinal Cord Injury

NCT04493372
recruitingnot_applicable

Deciphering Preserved Autonomic Function After Multiple Sclerosis

NCT07012135
completednot_applicable

Transcutaneous Spinal Cord Neuromodulation to Normalize Autonomic Phenotypes

NCT04858178

Clinical Trials (3)

Showing 3 of 3 trials
NCT04493372Not Applicable

Deciphering Preserved Autonomic Function After Spinal Cord Injury

Recruiting
NCT07012135Not Applicable

Deciphering Preserved Autonomic Function After Multiple Sclerosis

Recruiting
NCT04858178Not Applicable

Transcutaneous Spinal Cord Neuromodulation to Normalize Autonomic Phenotypes

Completed

All 3 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
3